VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma

Journal: Science

Published: 2018-07-20

DOI: 10.1126/science.aap8411

Affiliations: 17

Authors: 33

Go to article
Institutions FC
UNC Lineberger Comprehensive Cancer Center, United States of America (USA) 0.55
Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, United States of America (USA) 0.06
UNC Department of Biochemistry and Biophysics, United States of America (USA) 0.06
UNC Department of Pathology and Laboratory Medicine, United States of America (USA) 0.06
Huashan Hospital, Fudan University, China 0.03
Harvard Department of Systems Biology, United States of America (USA) 0.03
Department of Medical Oncology, DFCI, United States of America (USA) 0.03
Shanghai Tenth People's Hospital, Tongji University, China 0.03
Genome Institute of Singapore (GIS), A*STAR, Singapore 0.03
Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore 0.03
Duke-NUS Cancer and Stem Cell Biology Program (CSCB), Singapore 0.03
Division of Hematology-Oncology, VU, United States of America (USA) 0.02
Vanderbilt-Ingram Cancer Center (VICC), VU, United States of America (USA) 0.02
Laboratory of Cancer Epigenome, NCCS, Singapore 0.01
UNC Neuroscience Center, United States of America (USA) 0.01
UNC Department of Genetics, United States of America (USA) 0.01
UNC Department of Pharmacology, United States of America (USA) 0.01

Return